Influenza vaccine effectiveness in healthy 6- to 21-month-old children during the 2003-2004 season
Mandy A. Allison(National Center for Immunization and Respiratory Diseases), Allison Kempe(Children's Hospital Colorado), Norma J. Allred(National Center for Immunization and Respiratory Diseases), Jennifer Barrow(Children's Hospital Colorado), Brenda L. Beaty(University of Colorado Health), Lori A. Crane(Colorado School of Public Health), Stephen Berman(Day Family Medicine), Matthew F. Daley(Kaiser Permanente)
Cited by 123
Related Papers
Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices
|MMWR Morbidity and Mortality Weekly Report|2016|800
Effects of the COVID-19 Pandemic on Routine Pediatric Vaccine Ordering and Administration — United States, 2020
|MMWR Morbidity and Mortality Weekly Report|2020|720
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602
Predictors of nonadherence to screening colonoscopy
|Journal of General Internal Medicine|2005|290